LHIBRE 4G P/SUSP 50SB PVO FARMAC HISPAN P NETO Tratamiento de sangrados en pacientes

Description

Tratamiento de sangrados en pacientes con deficiencia congénita de factor VII

Concentración: 20 mg/mL (300 mg de natalizumab)

ZALTRAP ZIV 100 MG/4 ML | Frasco Ámpula | 1 UN | Sanofi Aventis

Requiere monitoreo cardíaco

DOSIS: 30 ML

LHIBRE 4G P/SUSP 50SB PVO FARMAC HISPAN P NETO Tratamiento de sangrados en pacientes

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy